Selected article for: "ace receptor target and acute respiratory syndrome"
Author: Barbalho, Sandra Maria; Matias, Julia Novaes; Flato, Uri Adrian Prync; Pilon, Joao Paulo Galletti; Bitelli, Piero; Pagani Junior, Marcos Alberto; de Carvalho, Antonelly Cassio Alves; Haber, Jesselina Francisco dos Santos; Reis, Carlos Henrique Bertoni; Goulart, Ricardo de Alvares
Title: What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?
  • Cord-id: 2l1bmtqn
  • Document date: 2021_2_19
    • ID: 2l1bmtqn
    Snippet: BACKGROUND: Inflammatory bowel diseases (IBD) are a group of immune and inflammatory diseases; and patients seem to be more vulnerable to influenza and coronavirus disease 2019 (COVID-19). These conditions are characterized by the augmented release of inflammatory cytokines that have been suggested as potential triggers for the acute respiratory distress syndrome, which may favor severe and even fatal outcomes. For these reasons, this review aims to evaluate what influenza and COVID-19 may repre
    Document: BACKGROUND: Inflammatory bowel diseases (IBD) are a group of immune and inflammatory diseases; and patients seem to be more vulnerable to influenza and coronavirus disease 2019 (COVID-19). These conditions are characterized by the augmented release of inflammatory cytokines that have been suggested as potential triggers for the acute respiratory distress syndrome, which may favor severe and even fatal outcomes. For these reasons, this review aims to evaluate what influenza and COVID-19 may represent for patients with IBD. METHODS: The search was performed in MEDLINE/PubMed, EMBASE, and Cochrane databases. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed to build the review. RESULTS: The conventional therapies used by IBD patients may also interfere in the outcomes of influenza and COVID-19. Immune-suppressors agents are associated with a higher risk of infections due to the inhibition of intracellular signals necessary to the host act against pathogens. On the other hand, drugs related to the suppression of the production of cytokines in IBD could bring benefits to reduce mucosal inflammation, and for preventing pneumonia. Moreover, coronaviruses can bind to the target cells through angiotensin-converting enzyme 2 (ACE-2) receptor that is expressed in epithelial cells of the lung and largely the colon and the terminal ileum suggesting that human intestinal tract could be an alternative route for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). CONCLUSIONS: Once the cytokine storm observed in influenza and COVID-19 is similar to the cytokine pattern observed in IBD patients during the disease flares, the advice is that avoiding the infections is still an optimal option for IBD subjects.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and active ibd: 1
    • abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abdominal pain and acute period: 1, 2, 3, 4
    • abdominal pain and acute pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • abdominal pain and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abdominal pain and lymph node: 1, 2, 3, 4, 5, 6, 7, 8
    • abstract title and acute ards respiratory distress syndrome: 1
    • abstract title and acute pneumonia: 1
    • abstract title and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace renin angiotensin system and acute ards respiratory distress syndrome: 1, 2, 3
    • ace renin angiotensin system and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • ace renin angiotensin system key enzyme and acute respiratory: 1, 2, 3
    • active ibd and acute respiratory: 1
    • active ibd presence and acute respiratory: 1
    • acute ards respiratory distress syndrome and lung alveolar cell: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lung epithelial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and lymph node: 1, 2
    • acute ards respiratory distress syndrome and macrophage response: 1, 2, 3, 4, 5